Topical retinoids in acne therapy

References

• Antonio JR. Acne e erupções acneiformes. In: Manual de Dermatologia. Cucé LC, Festa, Neto C (Eds). Atheneu, Rio de Janeiro, Brazil 99–117 (2001).
   Google Scholar
• Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne – a twin study. Br. J. Dermatol. 121, 144–145 (1989).
   PubMedGoogle Scholar
• Friedman GD. Twin studies of disease heritability based on medical records: application to acne vulgaris. Acta Genet. Med. Gemmellol. (Roma) 33, 487–495 (1984).
   PubMedGoogle Scholar
• Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br. J. Dermatol. 141, 297–300 (1999).
   PubMed Web of Science ®Google Scholar
• Schafer-Korting M, Korting HC, Ponce-Poschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Invest. 72, 1086–1091 (1994).
   PubMedGoogle Scholar
• Quigley JW, Bucks DA. Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system: A summary of preclinical and clinical investigations. J. Am. Acad. Dermatol. 38, 5–10 (1998).
   PubMed Web of Science ®Google Scholar
• Leyden JL. Emerging topical retinoid therapies. J. Am. Acad. Dermatol. 38,1–4 (1998).
   Google Scholar
• Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330, 444–50 (1987).
   PubMed Web of Science ®Google Scholar
• Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphagen retinoic acid. Nature 330, 624–629 (1987).
   PubMed Web of Science ®Google Scholar
• Vega B. Guest editorial: Acne vulgaris is a multifactorial disease. Presented at World Dermatology Congress, Paris, France July 1–5, 2002. Apud Leyden JJ. J. Am. Acad. Dermatol. 49(3 Suppl), S199 (2003).
   PubMedGoogle Scholar
• Chalker DK, Lesher JL Jr, Smith JG et al. Efficacy of topical isotretinoin 0,05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J. Am. Acad. Dermatol. 17, 251–254 (1987).
   PubMedGoogle Scholar
• Strauss JS, Rapini RP, Shalita AR et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J. Am. Acad. Dermatol. 10, 490–496 (1984).
   PubMed Web of Science ®Google Scholar
• Dunlap FE, Baker MD, Plott RT, Verschoore M. Adapalene 0,1% gel has low skin irritation potential even when applied immediately after washing. Br. J. Dermatol. 139(Suppl. 52), 23–25 (1998).
   PubMedGoogle Scholar
• Czernielewski J, Michel S, Bouclier M et al. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. JEADV. 15(Suppl. 3), 5–12 (2001).
   Google Scholar
• Shroot B. Pharmacodynamics and pharmacokinetics of topical adapalene. J. Am. Acad. Dermatol. 39, S17–S24 (1998).
   PubMed Web of Science ®Google Scholar
• Queille-Roussel C, Poncet M, Mesaros S et al. Comparison of the cumulative irritation potential of adapaleno gel and adapaleno solution (0.1%) with tazaroteno gel and several tretinoin formulations. Clin. Ther. 23, 205–212 (2001).
   PubMed Web of Science ®Google Scholar
• Latriano L, Tzimas G, Wong F, Wills RJ. The percutaneous absorption of topically applied tretinoin and its metabolites after single doses or long-term use. J. Am. Acad. Dermatol. 36, S37–46 (1997).
   Google Scholar
• Dominguez J, Hoyjo MT, Celayo JL et al. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int. J. Dermatol. 37, 54–55 (1998).
   PubMedGoogle Scholar
• Tu P, Li G-Q, Zhu X-J, Zheng, J, Wong W-Z. A comparison of adapalene gel 0.1% vs. tretinoin gel 0,025% in the treatment of acne vulgaris in China. JEADV 15(Suppl. 3), 31–36 (2001).
   Google Scholar
• Shalita A, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0,025% in the treatment of acne vulgaris: a multicenter trial. J. Am. Acad. Dermatol. 34, 482–485 (1996).
   PubMed Web of Science ®Google Scholar
• Caron D, Sorba V, Kerrouche N et al. Split-face comparison of adapalene 0,1% gel and tretinoin 0,025% gel in acne patients. J. Am. Acad. Dermatol. 36, S110–S112 (1997).
   Google Scholar
• Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0,1% gel versus tretinoin 0,025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials. Br. J. Dermatol. 139(Suppl. 52), 48–56 (1998).
   PubMed Web of Science ®Google Scholar
• Shalita AR, Chalker DK, Griffith RF et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris. Cutis 63, 349–354 (1999).
   PubMed Web of Science ®Google Scholar
• Bershad S, Poulin YP, Berson DS et al. Topical retinoids in treatment of acne vulgaris. Tazarotene versus tretinoin. Cutis 64(Suppl. 2), 8–20 (1999).
   PubMedGoogle Scholar
• Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br. J. Dermatol. 139(Suppl. 52), 8–11 (1998).
   PubMed Web of Science ®Google Scholar
• Gollnick, H. Current Perspectives on the treatment of acne vulgaris and implications for future directions, J. Eur. Acad. Dermatol. Venereol. 15(Suppl. 3), 1–4 (2001).
   PubMed Web of Science ®Google Scholar